The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Therapeutic peptides: technological advances driving peptides into development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
A peptide carrier for the delivery of biologically active proteins into mammalian cells
Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1173 · Cited by 1,018
Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein
Elliott, G., & O'Hare, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81843-7 · Cited by 972
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
Cell penetration by transportan
Pooga, M., Hällbrink, M., Zorko, M., & Langel, U. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.67 · Cited by 679
Engineering novel binding proteins from nonimmunoglobulin domains
Binz, H. K., Amstutz, P., & Plückthun, A. (2005) · Nature Biotechnology · doi:10.1038/nbt1127 · Cited by 676
Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin
Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., & Dower, W. J. (1996) · Science · doi:10.1126/science.273.5274.458 · Cited by 672
Strategies to improve plasma half life time of peptide and protein drugs
Werle, M., & Bernkop-Schnürch, A. (2006) · Amino Acids · doi:10.1007/s00726-005-0289-3 · Cited by 660
Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588
Wang, L., Xie, J., & Schultz, P. G. (2006) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.35.101105.121507 · Cited by 582
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
Deshayes, S., Morris, M. C., Divita, G., & Heitz, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5109-0 · Cited by 483
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Wyman, T. B., Nicol, F., Zelphati, O., Scaria, P. V., Plank, C., & Szoka, F. C. (1997) · Biochemistry · doi:10.1021/bi9618474 · Cited by 453
Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., & Bienert, M. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00161-8 · Cited by 448
Baggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2492 · Cited by 386
Phage display-derived peptides as therapeutic alternatives to antibodies
Ladner, R. C., Sato, A. K., Gorzelany, J., & de Souza, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03104-6 · Cited by 301
Self-citationDeletion analogues of transportan
Soomets, U., Lindgren, M., Gallet, X., Hällbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R., & Langel, Ü. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00216-9 · Cited by 283
Cell-Penetrating Peptides: Mechanisms and Applications
El-Andaloussi, S., Holm, T., & Langel, U. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774580796 · Cited by 242
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains
Silverman, J., Lu, Q., Bakker, A., To, W., Duguay, A., Alba, B. M., Smith, R., Rivas, A., Li, P., Le, H., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1166 · Cited by 237
Perspective – FcRn transports albumin: relevance to immunology and medicine
Anderson, C. L., Chaudhury, C., Kim, J., Bronson, C. L., Wani, M. A., & Mohanty, S. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.004 · Cited by 209
Protein Transduction: Cell Penetrating Peptides and Their Therapeutic Applications
Wagstaff, K., & Jans, D. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776872871 · Cited by 176
Rheumatoid Arthritis: An Overview of New and Emerging Therapies
Doan, T., & Massarotti, E. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005277938 · Cited by 171
Nguyen, A., Reyes, A. E., Zhang, M., McDonald, P., Wong, W., Damico, L. A., & Dennis, M. S. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl011 · Cited by 141
Monomeric Fc Fusions: Impact on Pharmacokinetic and Biological Activity of Protein Therapeutics
Dumont, J. A., Low, S. C., Peters, R., & Bitonti, A. J. (2006) · BioDrugs · doi:10.2165/00063030-200620030-00002 · Cited by 139
Dumont, J. A., Bitonti, A. J., Clark, D., Evans, S., Pickford, M., & Newman, S. P. (2005) · Journal of Aerosol Medicine · doi:10.1089/jam.2005.18.294 · Cited by 133
Design and Structure of Peptide and Peptidomimetic Antagonists of Protein- Protein Interaction
Sillerud, L. O., & Larson, R. A. (2005) · Current Protein and Peptide Science · doi:10.2174/1389203053545462 · Cited by 129
Screening for peptide drugs from the natural repertoire of biodiverse protein folds
Watt, P. M. (2006) · Nature Biotechnology · doi:10.1038/nbt1190 · Cited by 115
Stead, R. B., Lambert, J. S., Wessels, D., Iwashita, J., Leuther, K. K., Woodburn, K. W., Schatz, P. J., Okamoto, D. M., Naso, R. B., & Duliège, A. (2006) · Blood · doi:10.1182/blood-2006-04-015818 · Cited by 111
Johnson, D. L., Farrell, F. X., Barbone, F. P., McMahon, F. J., Tullai, J., Hoey, K., Livnah, O., Wrighton, N. C., Middleton, S. A., Loughney, D. A., et al. (1998) · Biochemistry · doi:10.1021/bi971956y · Cited by 100
He, X., Shaw, P., & Tam, S.-C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00257-x · Cited by 93
Wang, W. Q., Ou, Y. C., & Shi, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048203.30568.81 · Cited by 70
Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog
Léger, R., Thibaudeau, K., Robitaille, M., Quraishi, O., van Wyk, P., Bousquet-Gagnon, N., Carette, J., Castaigne, J., & Bridon, D. P. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.066 · Cited by 62
A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases
Shrivastava, A., von Wronski, M. A., Sato, A. K., Dransfield, D. T., Sexton, D. J., Bogdan, N. J., Pillai, R., Nanjappan, P., Song, B., Marinelli, E. R., et al. (2005) · Protein Engineering Design and Selection · doi:10.1093/protein/gzi049 · Cited by 55
Self-citationAdvancements in the Treatment of Psoriasis: Role of Biologic Agents
Rich, S. J., & Bello-Quintero, C. E. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.4.318 · Cited by 51
Giannoukakis, N. (2003) · PubMed · Cited by 30
Discovery of high-affinity peptide binders to BLyS by phage display
Fleming, T. J., Sachdeva, M., Delic, M., Beltzer, J. P., Wescott, C. R., Devlin, M., Lander, R. C., Nixon, A. E., Roschke, V. V., Hilbert, D. M., et al. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.722 · Cited by 30
Cited by
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
Diao, L., & Meibohm, B. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0079-0 · Cited by 369
Metadata
- Authors
- Sato, A. K., Viswanathan, M., Kent, R. B., & Wood, C. R.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 17
- Issue
- 6
- Pages
- 638-642
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W1993875393
- Cited by
- 362
- References
- 38
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.